Myocardial protection with enalaprilat in patients unresponsive to ischemic preconditioning during percutaneous coronary intervention

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 12, 2008, Pages 827-834

  Ungi, Imre ^a   Pálinkás, Attila ^b   Nemes, Attila ^a   Ungi, Tamás ^a   Thury, Attila ^a   Sepp, Róbert ^a   Horváth, Tamás ^a   Forster, Tamás ^a   Végh, Ágnes ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Erzsebet Hospital   (Hungary)

Author keywords

Angioplasty; Enalaprilat; Intracoronary ECG; Preconditioning; ST segment changes

Indexed keywords

BRADYKININ; ENALAPRILAT; ENAP; UNCLASSIFIED DRUG;

ADULT; AGED; AORTA BALLOON; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; INTRACORONARY INFUSION; ISCHEMIC PRECONDITIONING; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; ST SEGMENT ELEVATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ENALAPRILAT; FEMALE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; TIME FACTORS;

EID: 57349194538     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-096     Document Type: Article

References (34)

1. Ahmad, M., Zeitlin, I.J., Parratt, J.R., Valen, G., Takeshima, S., and Vaage, J. 1996. Changes in bradykinin levels in the blood of patients undergoing cardiopulmonary bypass. J. Physiol. 494: 116P-117P.
2. Airaksinen, K.E.J., and Huikuri, H.V. 1997. Antiarrhythmic effect of repeated coronary occlusion during balloon angioplasty. J. Am. Coll. Cardiol. 29: 1035-1038. doi:10.1016/S0735-1097(97)00042-9. PMID:9120156.
3. Baumgarten, C.R., Linz, W., Kunkel, G., Scholkens, B.A., and Wiemer, G. 1993. Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br. J. Pharmacol. 108: 293-295. PMID:8448580.
4. Billinger, M., Fleisch, M., Eberli, F.R., Garachemani, A., Meier, B., and Seiler, Ch. 1999. Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment? J. Am. Coll. Cardiol. 33: 1027-1035. doi:10.1016/S0735-1097(98)00674-3. PMID:10091831.
5. Bolli, R., Manchikalapudi, S., Tang, X.L., Takano, H., Qiu, Y., Guo, Y., et al. 1997. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ. Res. 81: 1094-1107. PMID:9400391.
6. Cohen, M., and Rentrop, K.P. 1986. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation, 74: 469-476. PMID:2943529.
7. Cohen, M.V., Liu, Y., and Downey, J.M. 1996. Activation of protein kinase C is critical to the protection of preconditioning. In Myocardial preconditioning. Edited by C.L. Wainwright and J.R. Parratt. Chapman & Hall RG Landes Co. pp. 185-206.
8. Dupouy, P., Geschwind, H., Pelle, G., Aptecar, E., Hittinger, L., El Ghalid, A., et al. 1996. Repeated coronary artery occlusions during routine balloon angioplasty do not induce myocardial preconditioning. in humans. J. Am. Coll. Cardiol. 27: 1374-1380. doi:10.1016/0735-1097(96)00029-0. PMID:8626946.
9. Friedman, P.L., Shook, T.L., Kirshenbaum, J.M., Selwyn, A.P., and Ganz, P. 1986. Value of the intracoronary electrogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty. Circulation, 74: 330-339. PMID:2942314.
10. Goto, M., Liu, Y., Yang, X.M., Ardell, J.L., Cohen, M.V., and Downey, J.M. 1995. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ. Res. 77: 611-621. PMID:7641331.
11. Johansen, O., Brekke, M., Stromme, J.H., Valen, V., Seljeflot, I., Skjaeggestad, O., et al. 1998. Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements. Eur. Heart J. 19: 112-117. doi:10.1053/euhj.1997.0732. PMID:9503183.
12. Kurz, T., Schafer, U., Dendorfer, A., Hartmann, F., Raasch, W., Tölg, R., et al. 2001. Effects of intracoronary low-dose enalaprilat as an adjunct to primary percutaneous transluminal coronary angiography in acute myocardial infarction. Am. J. Cardiol. 88: 1351-1357. doi:10.1016/S0002-9149(01)02112-9. PMID:11741551.
13. Laskey, W.K., and Beach, D. 2003. Frequency and clinical significance of ischemic preconditioning during percutaneous coronary intervention. J. Am. Coll. Cardiol. 42: 998-1003. doi:10.1016/S0735-1097(03)00909-4. PMID:13678919.
14. Leesar, M.A., Stoddard, M.F., Ahmed, M., Broadbent, J., and Bolli, R. 1997. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation, 95: 2500-2507. PMID:9184580.
15. Leesar, M.A., Stoddard, M.F., Manchikalapudi, S., and Bolli, R. 1999. Bradykinin-induced preconditioning in patients undergoing coronary angioplasty. J. Am. Coll. Cardiol. 34: 639-650. doi:10.1016/S0735-1097(99)00297-1. PMID:10483942.
16. Leesar, M.A., Stoddard, M.F., Dawn, B., Jasti, V.G., Masden, R., and Bolli, R. 2001. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation, 103: 2935-2941. PMID:11413083.
17. Leesar, M.A., Jneid, H., Tang, X.L., and Bolli, R. 2007. Pretreatment with intracoronary enalaprilat protects human myocardium during percutaneous coronary angioplasty. J. Am. Coll. Cardiol. 49: 1607-1610. doi:10.1016/j.jacc.2007.01.060. PMID:17433950.
18. Liu, G.S., Thornton, J., VanWinkle, D.M., Stanley, A.W., Olsson, R.A., and Downey, J.M. 1991. Protection against infarction afforded by preconditioning is mediated by A1-adenosine receptors in the rabbit heart. Circulation, 84: 350-356. PMID:2060105.
19. Martorana, P.A., Kettenbach, B., Breipohl, G., Linz, W., and Scholkens, B.A. 1990. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur. J. Pharmacol. 182: 395-396. doi:10.1016/0014-2999(90)90301-L. PMID:2397747.
20. Matsubara, T., Minatoguchi, S., Matsuo, H., Hayakawa, K., Segawa, T., Matsuno, Y., et al. 2000. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease. J. Am. Coll. Cardiol. 35: 345-351. doi:10.1016/S0735-1097(99) 00539-2. PMID:10676679.
21. Meier, B., Luethy, P., Finci, L., Steffenino, G.D., and Rutishauser, W. 1987. Coronary wedge pressure in relation to spontaneously visible and recruitable collaterals. Circulation, 75: 906-913. PMID:2952368.
22. Miki, T., Miura, T., Ura, N., Ogawa, T., Suzuki, K., Shimamoto, K., and Iimura, O. 1996. Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation. J. Am. Coll. Cardiol. 28: 1616-1622. doi:10.1016/S0735-1097(96)00371-3. PMID:8917279.
23. Mohri, M., Tagawa, H., Egashira, K., and Takeshita, A. 2000. Intracoronary enalaprilat improves metabolic coronary vasodilation in patients with idiopathic dilated cardiomyopathy. J. Cardiovasc. Pharmacol. 35: 249-255. doi:10.1097/00005344-200002000-00011. PMID:10672857.
24. Murry, C.E., Jennings, R.B., and Reimer, K.A. 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 74: 1124-1136. PMID:3769170.
25. Nozawa, Y., Miura, T., Tsuchida, A., Kita, H., Fukuma, T., and Shimamoto, K. 1999. Chronic treatment with an ACE inhibitor, temocapril, lowers the threshold for the infarct size-limiting effect of ischemic preconditioning. Cardiovasc. Drugs Ther. 13: 151-157. doi:10.1023/A:1007744428819. PMID:10372231.
26. Rundqvist, B., Eisenhofer, G., Emanuelsson, H., Albertsson, P., and Friberg, P. 1997. Intracoronary blockade of angiotensin-converting enzyme in humans: Interaction with cardiac sympathetic neurotransmission? Acta Physiol. Scand. 161: 15-22. doi:10.1046/j.1365-201X.1997.00199.x. PMID:9381945.
27. Schott, R.J., Rohmann, S., Braun, E.R., and Schaper, W. 1990. Ischemic preconditioning reduces infarct size in swine myocardium. Circ. Res. 66: 1133-1144. PMID:2317890.
28. Shattock, M.J., Lawson, C.S., Hearse, D.J., and Downey, J.M. 1996. Electrophysiological characteristics of repetitive ischemic preconditioning in the pig heart. J. Mol. Cell. Cardiol. 28: 1339-1347. doi:10.1006/jmcc. 1996.0124. PMID:8782075.
29. + channel blocker. Circulation, 90: 700-705. PMID:8044938.
30. Tomai, F., Crea, F., Chiariello, L., and Gioffre, P.A. 1999. Ischemic preconditioning in humans: models, mediators, and clinical relevance. Circulation, 100: 559-563. PMID:10430772.
31. Ungi, I., Ungi, T., Ruzsa, Z., Nagy, E., Zimmermann, Z., Csont, T., and Ferdinandy, P. 2005. Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coronary angioplasty. Chest, 128: 1623-1628. doi:10.1378/chest.128.3.1623. PMID:16162767.
32. Végh, Á., Szekeres, L., and Parratt, J.R. 1991. Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs. Br. J. Pharmacol. 104: 294-295.
33. Yasuda, T., Hashimura, K., Matsu-ura, Y., Kato, Y., Ueda, T., Mori, I., et al. 2001. Nicorandil, a hybrid between nitrate and ATP-sensitive potassium channel opener, preconditions human heart to ischemia during percutaneous transluminal coronary angioplasty. Jpn. Circ. J. 65: 526-530. doi:10.1253/jcj.65.526. PMID:11407735.
34. Yellon, D.M., and Baxter, G.F. 2000. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality? Heart, 83: 381-387. doi:10.1136/heart.83.4.381. PMID:10722532.